Join Fund Library now and get free access to personalized features to help you manage your investments.
Emerging Markets Equity
Close (12-05-2024) |
$28.77 |
---|---|
Change |
$0.07
(0.24%)
|
Open | $28.68 |
---|---|
Day Range | $28.68 - $28.83 |
Volume | 8,452 |
As at October 31, 2024
Inception Return (May 14, 2024): 5.85%
Row Heading | Return | Annualized Return | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
Fund | -0.23% | 3.93% | - | - | - | - | - | - | - | - | - | - | - | - |
Benchmark | -0.88% | 6.59% | 11.90% | 20.80% | 27.53% | 20.03% | 4.32% | 5.73% | 6.22% | 7.50% | 4.81% | 6.52% | 7.29% | 6.48% |
Category Average | -1.52% | 6.68% | 6.68% | 13.03% | 21.34% | 16.88% | 0.15% | 2.89% | 4.08% | 5.31% | 2.59% | 4.58% | 5.27% | 4.02% |
Category Rank | 54 / 342 | 133 / 340 | - | - | - | - | - | - | - | - | - | - | - | - |
Quartile Ranking | 1 | 2 | - | - | - | - | - | - | - | - | - | - | - | - |
Return % | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fund | - | - | - | - | - | - | - | 2.93% | 1.67% | -1.51% | 5.77% | -0.23% |
Benchmark | 4.87% | 0.67% | -2.21% | 5.63% | 1.24% | 3.23% | 0.38% | 3.25% | 1.30% | -0.40% | 7.98% | -0.88% |
5.77% (September 2024)
-2.67% (May 2024)
Return % | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Fund | - | - | - | - | - | - | - | - | - | - |
Benchmark | 8.76% | 2.69% | 7.90% | 26.42% | -6.05% | 15.55% | 11.45% | 0.08% | -12.38% | 7.03% |
Category Average | 2.91% | -3.92% | 6.53% | 28.88% | -11.86% | 15.06% | 17.52% | -3.30% | -17.32% | 8.68% |
Quartile Ranking | - | - | - | - | - | - | - | - | - | - |
Category Rank | - | - | - | - | - | - | - | - | - | - |
-
-
Standard Deviation | - | - | - |
---|---|---|---|
Beta | - | - | - |
Alpha | - | - | - |
Rsquared | - | - | - |
Sharpe | - | - | - |
Sortino | - | - | - |
Treynor | - | - | - |
Tax Efficiency | - | - | - |
Volatility | - | - | - |
Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
---|---|---|---|---|
Standard Deviation | - | - | - | - |
Beta | - | - | - | - |
Alpha | - | - | - | - |
Rsquared | - | - | - | - |
Sharpe | - | - | - | - |
Sortino | - | - | - | - |
Treynor | - | - | - | - |
Tax Efficiency | - | - | - | - |
Start Date | May 14, 2024 |
---|---|
Instrument Type | Exchange Traded Fund |
Share Class | Do-It-Yourself |
Legal Status | - |
Sales Status | Open |
Currency | CAD |
Distribution Frequency | Annual |
Assets ($mil) | - |
52 Week High | $29.99 |
52 Week Low | $26.04 |
Annual Dividend | - |
Annual Yield | - |
Index | - |
Shares Outstanding | - |
Registered Plan Eligible | Yes |
Exposure | - |
---|---|
Asset Class High | - |
Asset Class Medium | - |
Asset Class Low | - |
Leveraged | - |
Inverse | - |
Advisor Series | - |
Covered Call Strategy | No |
The ETF seeks to replicate, to the extent reasonably possible and net of expenses, the performance of an index that is designed to measure the performance of the large and mid-cap securities across emerging markets countries (currently, the MSCI Emerging Markets Index).
In order to achieve their investment objectives and obtain direct or indirect exposure to securities of their Underlying Index’s Constituent Issuers, the Index ETFs may invest in and hold the securities of Constituent Issuers in substantially the same proportion as they are reflected in the applicable Underlying Index, or may invest in and hold index participation units of exchange traded funds or use derivatives
Name | Start Date |
---|---|
Global X Investments Canada Inc. | 05-15-2024 |
Fund Manager | Global X Investments Canada Inc. |
---|---|
Advisor | Global X Investments Canada Inc. |
Custodian | CIBC Mellon Trust Company |
Registrar | TSX Trust Company |
Distributor | - |
Auditor | KPMG LLP |
MER | - |
---|---|
Management Fee | 0.25% |
Join Fund Library now and get free access to personalized features to help you manage your investments.